Dengue vaccine: a key for prevention

ABSTRACT

Introduction

Dengue infection is the most important mosquito-borne viral disease in the world. Most mosquito control methods currently available for public health use are not very efficacious. Dengue vaccine is required to control dengue diseases in the future through the use of a safe and effective vaccine.

Areas covered

This review covered dengue vaccine development and candidate dengue vaccines in the clinical trial pipeline including licensed dengue vaccine.

Expert opinion

Dengue has become an intractable global health problem. Vector control has achieved only limited success in reducing the transmission of dengue. A dengue vaccine is needed as part of an integrated approach to dengue prevention and control since dengue poses a heavy economic cost to the health system and society. Because dengue is a unique and complex disease developing a dengue vaccine has proven equally complex. However, there is an advanced pipeline of vaccine research currently in clinical and preclinical studies including live-attenuated vaccine candidates as well as virus-vectored and virus-like particle-based vaccines.

KEYWORDS:

• Global threat of dengue
• dengue vaccine development
• dengue vaccines in the clinical trial pipeline
• licensed dengue vaccine

Article highlights

• Dengue vaccine development

• Different approaches in dengue vaccine development

• Licensed dengue vaccine

• Dengue vaccines in the pipeline

• Expert opinion

Declaration of interest

No potential conflict of interest was reported by the authors.